Page 2 - Best Thyroid cancer doctors in Istanbul: TOP 28 doctors

Prof. Gul Alco specializes in radiation oncology for thyroid cancer at Istanbul Medipol University, bringing decades of dedicated experience.

• Professor in Radiation Oncology with extensive training and academic roles
• Completed residency at Kadir Has University's radiation oncology department
• Works at Istanbul Medipol University's advanced radiation oncology facility
• Academic focus on precise radiation therapy techniques

Professor of Medical Oncology with 15+ years of dedicated experience at Gayrettepe Florence Nightingale Hospital.

• Specialized in gastrointestinal oncology
• Member of ESMO and ASCO – leading oncology societies
• Fellowship-trained at Istanbul University Oncology Institute

Prof. Sezer Sağlam is a professor in medical oncology with extensive experience in thyroid cancer treatment at Gayrettepe Florence Nightingale Hospital.

• Trained at Istanbul University's Oncology Institute
• Specializes in gastrointestinal oncology
• Member of ESMO, ASCO, and Turkish Medical Oncology Association
• Over 20 years of professional experience in oncology

Specializes in thyroid cancer and other oncological conditions with training at prestigious international centers like MD Anderson Cancer Center and Sunnybrook Odette Cancer Center.

• Medical oncology specialist with expertise in thyroid cancer cases
• Trained in leading cancer centers in the USA and Canada
• Works at Valued Med Hub Hospitals
• Board-certified with extensive medical oncology background

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.